The regulator said it withdrew authorisation for the drug on Sept. 25. It added that the authorisation holder, listed as ...

Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to ...

Office of Prescription Drug Promotion (OPDP) recently sent an Untitled Letter to AbbVie, Inc., regarding a television ad starring Serena Williams for its migraine medicine Ubrelvy. According to the ...

The Untitled Letter addresses a television advertisement for Ubrelvy that features Serena Williams. Among other issues cited ...

Leerink Partners analyst David Risinger has maintained their neutral stance on ABBV stock, giving a Hold rating on September 13. David ...

Spherix Global Insights has provided a different angle on AbbVie’s successful retention of Humira sales in the face of ...

With Tremfya also securing approval in UC earlier this month, competition promises to be fierce among the IL-23s, according to .EXTON, PA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The past twelve months have ...

The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that ...

A roundup of current health news includes Johnson & Johnson's $2 billion investment in a new manufacturing facility, CVS ...

AbbVie announced positive topline results from its Phase III TEMPO-1 trial for tavapadon as a monotherapy for early Parkinson ...

AbbVie ABBV announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approving the ...